Daniel H Appella

13PUBLICATIONS
20CO-AUTHORS
Biologically active moleculesMolecular targetsPredictive and prognostic markersMedical parasitologyNanotoxicology, health and safety
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Dec 10, 2025
Sulfanylbenzamides with Unique Side Chains to Improve Metabolic Stability, Pharmacokinetics, and Anti-HIV Activity.

Marco Robello, Riley F Lehman, Daniel H Appella

|Nov 14, 2024
Covalent Modification of p53 by (<i>E</i>)-1-(4-Methylpiperazin-1-yl)-3-(5-nitrofuran-2-yl)prop-2-en-1-one.

Kate Brown, Marco Robello, Andrew J Perciaccante

|Jun 27, 2024
Detecting the <i>FLJ22447</i> lncRNA in Ovarian Cancer with Cyclopentane-Modified FIT-PNAs (cpFIT-PNAs).

Sheethal Thomas Mannully, Rawan Mahajna, Huda Nazzal

|Jan 22, 2024
Prodrug Strategy Extends the Use of Anti-HIV Sulfanylbenzamides for Application <i>In Vivo</i>.

Marco Robello, Herman Nikolayevskiy, Michael T Scerba

Pageof 3